Atrogi has dosed the first volunteers in a human trial of ATR-258, a muscle-preserving drug designed to help people lose fat without losing muscle. The eight-week...
MINNESOTA-based Medtronic has agreed to acquire neurovascular technology company Scientia Vascular for US$550m. Scientia’s neurovascular access devices are used to navigate the brain’s complex vasculature, helping...
A new report by Clue has revealed the ‘Cost of Bleeding’ – a deep dive into the true cost of menstruation and the impact of related...
Osteoporosis drugs may lower dementia risk, with a study suggesting one widely used treatment could help prevent Alzheimer’s and related dementias. The research found that nitrogen-containing...
Routine blood pressure checks could help flag dementia risk, according to two studies tracking changes in blood vessel stiffness over time. The findings add to growing...
A prebiotic fibre supplement may ease arthritis pain and improve grip strength in people with knee osteoarthritis, a study suggests. The daily supplement, made from inulin,...
An NHS diabetes drug costing as little as 2p a tablet could cut prostate cancer risk by more than a third, a study suggests. Metformin is...
MemoryAid, a phone-like device for dementia care, has shown positive trial results and is due to launch to the public this year. Developed by a team...
Vision-restoration company Science Corp has closed a US$230m Series C financing round which will allow it to complete the commercialisation of its brain-computer interface, retinal implant,...
An Alzheimer’s mutation may delay disease onset by about 20 years in people otherwise expected to develop memory loss in their mid-40s. The mutation affects a...
